-
New Buprenorphine for OUD Labels Clarify Higher Doses Appropriate for Some Patients
Full story -
ASAM Applauds House Passage of SUPPORT Reauthorization Act
Full story -
The ASAM Weekly for June 3rd, 2025
Memory function in patients with opioid dependence treated with buprenorphine and methadoneFull story -
Breaking Down the One Big Beautiful Bill Act: Select Health Care Provisions Impacting Addiction Medicine
Full story -
Members of Congress: Increase Funding for SUD Workforce Programs
Full story -
The ASAM Weekly for May 27th, 2025
Medicaid Unwinding and Changes in Buprenorphine DispensingFull story -
The ASAM Weekly for May 20th, 2025
Loneliness Among US Veterans With Problematic Substance UseFull story -
PSAM Urges Philadelphia Mayor to Veto Legislation Restricting Crucial Medical Services
Full story -
Letter: HHS Cuts Will Hurt Tobacco Cessation Programs and Product Regulation
Full story -
Advocacy Toolkit: Eliminate the Prohibition on the Prescribing of Methadone for OUD
Full story -
The ASAM Weekly for May 13th, 2025
Perspective on the Effects of Policies on Reducing Alcohol ConsumptionFull story -
ASAM: Sweeping Medicaid Reforms Could Weaken America’s Addiction Treatment Efforts, Pose a National Security Threat
Full story -
ASAM's Suggestions to Fix Burdensome Regulations Impeding Addiction Care
Full story -
The ASAM Weekly for May 6th, 2025
Building Multidisciplinary Consensus on Inpatient Xylazine ManagementFull story -
ASAM Joins Coalition Letter in Support of Funding for CDC's Office on Smoking and Health
Full story -
President Trump's First 100 Days: Addiction Policy
Full story -
ASAM Calls for Policies to Establish the Financial Sustainability of Addiction Treatment Services
Full story -
The ASAM Weekly for April 29th, 2025
Varenicline for Youth Nicotine Vaping CessationFull story -
ASAM Names New President: Stephen M. Taylor, MD, MPH
Full story -
The ASAM Weekly for April 22nd, 2025
Comprehensive drug policies increase trust in local governmentFull story